Wikipedia

Gomathy Babu Sadacharam Kulandaivelu

Gomathy Babu Sadacharam Kulandaivelu Velu[1] (also known as G. S. K. Velu) is an Indian healthcare entrepreneur.[2][3] He is the founder of Trivitron Healthcare and Neuberg Diagnostics, companies operating in the medical technology and diagnostics sectors in India and abroad.[4]

Gomathy Babu Sadacharam Kulandaivelu
Born
Aralvaimozhy, Kanyakumari district, Tamil Nadu, India
Alma mater
OccupationsHealthcare entrepreneur, business executive
TitleHonorary Consul of the Republic of Estonia

Early life and education

edit

Velu was born in Aralvaimozhy, Kanyakumari district, Tamil Nadu.[5][6] He attended a Tamil‑medium school near Madurai before earning a pharmacy degree from BITS Pilani in 1988[7] and an MBA from Loyola Institute of Business Administration, Chennai. He later completed doctoral studies in pharmacology at IBAM, Kolkata,[8] and was later awarded an honorary doctorate by Vel's University.[7][5]

Career

edit

Velu began his career in the medical devices and diagnostics sector in the late 1980s, working in technical and regional roles with companies involved in medical equipment and laboratory diagnostics in India and Southeast Asia.[7]

In 1997, he founded Trivitron Healthcare in Chennai.[7][9] The company initially operated as a distributor for international medical equipment brands before moving into manufacturing.[6][10] In the mid-2010s, Trivitron established a medical technology park in Chennai as part of its manufacturing expansion.[11][12]

In 1999 Velu acquired a 50% stake in a pathology laboratory business in Mumbai, which was later corporatized as Metropolis Healthcare.[13] His family retained a significant minority shareholding alongside the founding promoters and financial investors.[14][15] He exited the company in 2015 by selling his remaining stake to private equity firm The Carlyle Group, following a shareholder dispute relating to management control and stake dilution.[16][17][18]

Neuberg Diagnostics

edit

In 2017, Velu re-entered the diagnostic sector by founding Neuberg Diagnostics,[19][20] an alliance of pathology laboratories operating across India and selected international markets.[21] By the mid-2020s, Neuberg Diagnostics had established laboratory operations in India, the United Arab Emirates, and South Africa.[8][22][23]

Maxivision Eye Hospitals and other ventures

edit

Velu partnered with ophthalmologist Kasu Prasad Reddy in the expansion of Maxivision Eye Hospitals, which operates a network of specialty eye hospitals and clinics across multiple regions in India.[24][25] In 2016, Velu invested in Kauvery Hospital, a Chennai-based hospital chain, where he holds a minority stake and serves on the board of directors. The group operates hospitals across Tamil Nadu and Karnataka.[26] He has also entered into joint venture arrangements with Apollo Hospitals, resulting in minority shareholdings in Apollo Dialysis Clinics and Apollo Dental Ventures, which operate specialty dialysis and dental clinic networks in India.[27]

Public and diplomatic roles

edit

Velu has been active in industry advocacy, serving as the chairperson of the Tamil Nadu State Council for the Federation of Indian Chambers of Commerce & Industry (FICCI) in 2021.[28] In 2023, he was appointed as the Honorary Consul of the Republic of Estonia for the South Indian states of Tamil Nadu, Kerala, Andhra Pradesh, and Telangana.[26]

Awards and recognition

edit

In 2017, Velu received the Industry Achievement Award in Medical Technology from Hurun Report India.[29] He was later conferred the Cross of Merit by the Republic of Estonia for contributions to bilateral engagement.[30][31] In 2024, he received an honorary doctorate from VISTAS.[32]

Challenges and controversies

edit

Metropolis Healthcare boardroom dispute

edit

In 2015, a public boardroom dispute arose between Velu and the Shah family, in which Velu held a stake. The dispute followed a transaction in which the Shah family, led by managing director Ameera Shah, increased their stake from 36% to 63% by purchasing the 27% shareholding held by private equity firm Warburg Pincus, resulting in a shift in management control.[33][13] Velu alleged that the transaction had been carried out without adequate consultation and that his rights as a co-promoter had been bypassed.[34]

In September 2015, the matter concluded when Velu divested his remaining stake in Metropolis Healthcare to private equity firm The Carlyle Group for an estimated ₹850–900 crore, marking his exit from the company.[35][13]

Non-compete allegations

edit

In 2017, The Carlyle Group issued a notice to Velu concerning potential breach of a non-compete agreement associated with Velu's 2015 exit from Metropolis Healthcare.[16][36] The concerns were linked to his subsequent investments in the diagnostics sector through Neuberg Diagnostics. Velu denied any contractual violation, stating that he had complied with the terms of his exit agreement and that no legal proceedings were pending at the time.[19]

References

edit
  1. ↑ "Välisministeerium tunnustab kodanikupäeval rahvadiplomaate". Kesknädal (in Estonian). 2021-11-27. Retrieved 2026-01-13.
  2. ↑ Chaki, Deborshi (5 April 2017). "India: Carlyle threatens legal action against healthcare entrepreneur G.S.K. Velu". DealStreetAsia. Retrieved 2026-01-13.
  3. ↑ Shah, Sneha (2017-12-14). "Entrepreneur Velu back in diagnostics". The Economic Times. ISSN 0013-0389. Retrieved 2026-01-13.
  4. ↑ "Healthcare entrepreneur GSK Velu to start food testing company". The Times of India. 2016-07-12. ISSN 0971-8257. Retrieved 2026-01-13.
  5. 1 2 Mandlecha, Gaurav; Sethi, Durjai (2021-08-03). The Pilani Pioneers: Inspiring Success Stories of 25 BITS Pilani Graduates. Pan Macmillan. ISBN 978-81-949707-8-1.
  6. 1 2 Govardan, D (2022-05-16). "Life gave him tests, he made a career out of it". The Times of India. ISSN 0971-8257. Retrieved 2026-01-13.
  7. 1 2 3 4 Gupta, Aparajita (2011-10-06). "Equipped To Succeed". The Times of India. ISSN 0971-8257. Retrieved 2026-01-13.
  8. 1 2 Bose, Sajal (2023-09-22). "Neuberg's healthy growth". Business India. Retrieved 2026-01-13.
  9. ↑ "Metropolis founder Velu in talks with PEs for stake sale".
  10. ↑ Julka, Harsimran; Abrar, Peerzada (2013-02-08). "India spawning top notch medical devices companies with cutting-edge tech at affordable prices". The Economic Times. ISSN 0013-0389. Retrieved 2026-01-02.
  11. ↑ Kannan-Narasimhan, Rangapriya; Arcodia, Antonio; Patnaik Bhogela, Lokapati; Siddalinga Swamy, Prakruti; Syed, Jennifer. Trivitron's India-Born Global Story: Moving Up the Value Chain by Investing in the Power of People. 1 Oliver's Yard, 55 City Road, London EC1Y 1SP United Kingdom: SAGE Publications: SAGE Business Cases Originals. doi:10.4135/9781529740660. ISBN 978-1-5297-4066-0.{{cite book}}: CS1 maint: location (link) CS1 maint: publisher location (link)
  12. ↑ "Trivitron, BioSystems, Spain to set up facility in Chennai". The Economic Times. 2009-04-22. ISSN 0013-0389. Retrieved 2026-01-05.
  13. 1 2 3 Lall, Priti (2016-01-19). "How Ameera Shah took control of the Metropolis diagnostics chain". Mint. Retrieved 2026-01-13.
  14. ↑ "Trivitron and the Impending Rise of Medical Technology". www.forbesindia.com. Retrieved 2026-01-13.
  15. ↑ "Metropolis promoter rules out stake sale in near future - BusinessToday". Business Today. 2015-01-14. Retrieved 2026-01-13.
  16. 1 2 "Carlyle may lock horns with health entrepreneur GSK Velu over non-compete clause". VCCircle. 2017-04-05. Retrieved 2026-01-13.
  17. ↑ "Carlyle Group unit buys stake in India lab operator Metropolis Healthcare". Reuters. 9 September 2015. Retrieved 2026-01-13.
  18. ↑ Tudor-Ackroyd, Alison. "Carlyle ends boardroom spat at India's Metropolis". FinanceAsia. Retrieved 2026-01-11.
  19. 1 2 "GSK Velu's game plan in diagnostics business after Metropolis exit". VCCircle. 2017-12-14. Retrieved 2026-01-13.
  20. ↑ Hariharan, Sindhu (2025-11-03). "Healthcare entrepreneur GSK Velu preparing firms for public listing". BusinessLine. Retrieved 2026-01-13.
  21. ↑ "Bottomline: Can GSK Velu's Neuberg Diagnostics sustain its acquisition-led growth?". VCCircle. Retrieved 2026-01-13.
  22. ↑ Babu, Gireesh (6 September 2019). "Serial entrepreneur G S K Velu to ramp up diagnostics biz in west and south". BusinessStandard. Retrieved 2026-01-13.
  23. ↑ Sanjay, Satviki (11 November 2025). "Neuberg Diagnostics Said to Eye $350 Million India IPO in 2026". Bloomberg. Retrieved 2026-01-13.
  24. ↑ "Maxivision Group invests in Ojas Group to expand eye hospital network in Maharashtra". The Hindu. 2025-02-14. ISSN 0971-751X. Retrieved 2026-01-13.
  25. ↑ Balakrishnan, Reghu. "G.S.K. Velu's eye care chain seeks Rs200 crore funds". mint. Retrieved 2026-01-13.
  26. 1 2 "GSK Velu is FICCI T.N. Chair". The Hindu. 2022-01-28. ISSN 0971-751X. Retrieved 2026-01-13.
  27. ↑ P, Suraksha (2019-08-14). "Neuberg and GSK Velu's path(lab) to diagnostics redemption". The Ken. Retrieved 2026-01-13.
  28. ↑ Revathi, J.; Rani, S. Jansi (2019-04-01). "Analysis of Factors Influencing Medical Tourism in India Chennai and its Impacts". Indian Journal of Public Health Research & Development. 10 (4): 113. doi:10.5958/0976-5506.2019.00674.0. ISSN 0976-0245.
  29. ↑ "Zoho, Pothys and Hatsun Agro appear on IIFL Wealth Hurun India Rich List 2019". The Times of India. 2020-02-18. ISSN 0971-8257. Retrieved 2026-01-13.
  30. ↑ "Foreign Minister awards Crosses of Merit for contributions to Estonian statehood and foreign policy | Välisministeerium". www.vm.ee. Retrieved 2026-01-13.
  31. ↑ "Foreign minister honors contributions to Estonian statehood, foreign policy". ERR. 9 November 2022. Retrieved 2026-01-13.
  32. ↑ "Ram Charan awarded honorary doctorate in literature from Vels University". The Hindu. 2024-04-13. ISSN 0971-751X. Retrieved 2026-01-13.
  33. ↑ www.ETHealthworld.com. "Metropolis boardroom becomes a battleground: Warburg Pincus' stake sale to Shahs irks partner Velu". ETHealthworld.com | Pharma. Retrieved 2026-01-13.
  34. ↑ Kurian, Boby; Ramalingam, Aparna (2015-07-02). "Carlyle may end Metropolis feud with Rs 900cr stake buy". The Times of India. Retrieved 2026-01-02.
  35. ↑ "Carlyle buys GSK Velu's stake in pathology chain Metropolis". VCCircle. Retrieved 2026-01-13.
  36. ↑ Chaki, Deborshi. "Carlyle threatens legal action against G.S.K. Velu". mint. Retrieved 2026-01-13.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Gomathy_Babu_Sadacharam_Kulandaivelu&oldid=1355687681"